WallStreetZenWallStreetZen

NASDAQ: IVA
Inventiva Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IVA

Based on 4 analysts offering 12 month price targets for Inventiva Sa

Min Forecast
$13.00+146.26%
Avg Forecast
$18.00+240.97%
Max Forecast
$26.00+392.52%

Should I buy or sell IVA stock?

Based on 4 analysts offering ratings for Inventiva Sa.

Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IVA stock forecasts and price targets.

IVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-03
lockedlocked$00.00+00.00%2025-09-02Find Out Why
lockedlocked$00.00+00.00%2025-08-27
lockedlocked$00.00+00.00%2025-04-02

1 of 1

Forecast return on equity

Is IVA forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is IVA forecast to generate an efficient return on assets?

Company
-24.79%
Industry
47.48%
IVA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IVA earnings per share forecast

What is IVA's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$1.26
Avg 2 year Forecast
-$1.24
Avg 3 year Forecast
-$1.34

IVA revenue forecast

What is IVA's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$13.4M-12.66%
Avg 2 year Forecast
$6.0M-60.88%
Avg 3 year Forecast
$12.4M-19.32%
IVA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IVA revenue growth forecast

How is IVA forecast to perform vs Biotechnology companies and vs the US market?

Company
-12.53%
Industry
83.67%
Market
10.8%
IVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IVA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IVA$5.28$18.00+240.97%Strong Buy
VSTM$9.44$14.00+48.31%Strong Buy
ARCT$18.05$52.29+189.67%Strong Buy
KOD$9.21$9.00-2.28%Sell
CMPX$3.51$16.60+372.93%Strong Buy
View Top Biotech Stocks

Inventiva Sa Stock Forecast FAQ

Is Inventiva Sa Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: IVA) stock is to Strong Buy IVA stock.

Out of 4 analysts, 2 (50%) are recommending IVA as a Strong Buy, 2 (50%) are recommending IVA as a Buy, 0 (0%) are recommending IVA as a Hold, 0 (0%) are recommending IVA as a Sell, and 0 (0%) are recommending IVA as a Strong Sell.

If you're new to stock investing, here's how to buy Inventiva Sa stock.

What is IVA's earnings growth forecast for 2025-2027?

(NASDAQ: IVA) Inventiva Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.2%.

Inventiva Sa's earnings in 2025 is -$204,680,000.On average, 5 Wall Street analysts forecast IVA's earnings for 2025 to be -$120,725,937, with the lowest IVA earnings forecast at -$147,320,082, and the highest IVA earnings forecast at -$87,052,776. On average, 5 Wall Street analysts forecast IVA's earnings for 2026 to be -$119,004,014, with the lowest IVA earnings forecast at -$172,192,304, and the highest IVA earnings forecast at -$77,486,537.

In 2027, IVA is forecast to generate -$128,426,760 in earnings, with the lowest earnings forecast at -$232,459,610 and the highest earnings forecast at -$59,310,682.

What is IVA's revenue growth forecast for 2025-2027?

(NASDAQ: IVA) Inventiva Sa's forecast annual revenue growth rate of -12.53% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 83.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.8%.

Inventiva Sa's revenue in 2025 is $16,361,111.On average, 3 Wall Street analysts forecast IVA's revenue for 2025 to be $1,281,493,390, with the lowest IVA revenue forecast at $921,228,825, and the highest IVA revenue forecast at $1,464,591,206. On average, 1 Wall Street analysts forecast IVA's revenue for 2026 to be $573,974,346, with the lowest IVA revenue forecast at $573,974,346, and the highest IVA revenue forecast at $573,974,346.

In 2027, IVA is forecast to generate $1,183,822,089 in revenue, with the lowest revenue forecast at $573,974,346 and the highest revenue forecast at $1,793,669,831.

What is IVA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: IVA) forecast ROA is -24.79%, which is lower than the forecast US Biotechnology industry average of 47.48%.

What is IVA's Price Target?

According to 4 Wall Street analysts that have issued a 1 year IVA price target, the average IVA price target is $18.00, with the highest IVA stock price forecast at $26.00 and the lowest IVA stock price forecast at $13.00.

On average, Wall Street analysts predict that Inventiva Sa's share price could reach $18.00 by Sep 3, 2026. The average Inventiva Sa stock price prediction forecasts a potential upside of 240.97% from the current IVA share price of $5.28.

What is IVA's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: IVA) Inventiva Sa's current Earnings Per Share (EPS) is -$3.42. On average, analysts forecast that IVA's EPS will be -$1.26 for 2025, with the lowest EPS forecast at -$1.54, and the highest EPS forecast at -$0.91. On average, analysts forecast that IVA's EPS will be -$1.24 for 2026, with the lowest EPS forecast at -$1.80, and the highest EPS forecast at -$0.81. In 2027, IVA's EPS is forecast to hit -$1.34 (min: -$2.43, max: -$0.62).

What is IVA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: IVA) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.